OREGON COMMUNITY FOUNDATION sold $49K of JCTC

OREGON COMMUNITY FOUNDATION sold 19,718 shares of JEWETT CAMERON TRADING CO LTD (JCTC) at an average of $2.51 ($2.50–$2.51) across 2 trades over 2026-07-07 to 2026-07-08.

Original reporting
SEC EDGAR · OREGON COMMUNITY FOUNDATION
Published Jul 9, 2026, 1:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 9, 2026, 1:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$JCTC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

No new company fundamentals are disclosed. The filing only reports that 19,718 shares were sold at about $2.505 per share across two days, leaving 743,816 shares.

02

Market read

Traders may note the insider selling activity, but there is no accompanying guidance, earnings, or regulatory/contract catalyst in the text.

03

What to watch

Form 4 does not indicate whether the seller’s remaining holdings will be reduced further, and it does not provide reasons for the sale.

Relevance 3/10Novelty 2/10Timing: filed 2026-07-08 after-hours; covers sales dated 2026-07-07 to 2026-07-08

Background

The article is an SEC Form 4 insider transaction disclosure (open-market sale) reported by Oregon Community Foundation for JEWETT CAMERON TRADING CO LTD.

Market effects

None. This is a single insider sale disclosure with no operational or financial update.

None.

None.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as discretionary selling, but the transaction size is small and provides no fundamental signal by itself.

Key entities

  • JEWETT CAMERON TRADING CO LTD

    Subject of the Form 4 insider transaction; reported open-market sale of 19,718 shares at ~$2.505 per share.

  • OREGON COMMUNITY FOUNDATION

    Reporter of the Form 4 transaction; listed as a 10% owner.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).